Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Zhong C et al. | 2012 | intact cell/cell culture, mesenchymal bone marrow stem cells of mice (rat?, remark EMF-Portal: contradictory information) | magnetic field, low frequency, 50/60 Hz | 0.5 mT |
| Chen G et al. | 2012 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/S288C | GSM, mobile communications, RF, PW pulsed wave, magnetic field, low frequency, 50/60 Hz | 0.4 mT |
| Huwiler SG et al. | 2012 | bacterium, <i>Escherichia coli</i>/K12 MG1655 | magnetic field, 50/60 Hz, power transmission line | 1 mT |
| Fedrowitz M et al. | 2012 | animal, rat/Fischer 344 and Lewis, whole body | magnetic field, low frequency, 50/60 Hz | 100 µT |
| Patruno A et al. | 2012 | intact cell/cell culture, THP-1 cells (human monocytic leukemia cell line) | magnetic field, low frequency, 50/60 Hz, co-exposure | 1 mT |
| Bouwens M et al. | 2012 | intact cell/cell culture, Detroit 562 cells (human pharyngeal cells), THP-1 cells (human monocytic leukemia cell line) and human monocytes | magnetic field, low frequency, 50/60 Hz | 5 µT |
| Shin EJ et al. | 2011 | animal, mouse/C57BL/6, whole body | magnetic field, 50/60 Hz, co-exposure | 0.3–2.4 mT |
| Sulpizio M et al. | 2011 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
| Zhou J et al. | 2011 | intact cell/cell culture, osteoblasts | magnetic field, low frequency, 50/60 Hz | 0.9–4.8 mT |
| Gomez-Ochoa I et al. | 2011 | intact cell/cell culture, mononuclear cells (from human peripheral blood) | magnetic field, signals/pulses, 50/60 Hz, electrotherapy | 2.25 mT |
| Heredia-Rojas JA et al. | 2010 | intact cell/cell culture, INER-37 (human non-small-cell lung cancer cell line) and RMA E7 cells (E7-transfected mouse RMA lymphoma cells), transfected with the plasmid pEMF (electromagnetic field plasmid containing hsp70 promotor and the luciferase gene as reporter gene) | magnetic field, 50/60 Hz | 8–80 µT |
| Reyes-Guerrero G et al. | 2010 | animal, rat/Wistar, whole body | magnetic field, low frequency, 50/60 Hz | 1 mT |
| Patruno A et al. | 2010 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz, electrotherapy | 1 mT |
| Girgert R et al. | 2009 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Wang X et al. | 2008 | bacterium, <i>Magnetospirillum magneticum</i>/AMB-1 | magnetic field, geomagnetic field, 50/60 Hz | 0–1 mT |
| Masiuk M et al. | 2008 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), K-562 (chronic myelogenous leukemia) | magnetic field, 50/60 Hz | 10–20 mT |
| Falone S et al. | 2008 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 0.1 mT |
| Benfante R et al. | 2008 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, signals/pulses, 50/60 Hz, power transmission line | 1–2 mT |
| Delle Monache S et al. | 2008 | intact cell/cell culture, human vein endothelial cells (HUVEC) | magnetic field, low frequency, 50/60 Hz | 1 mT |
| Vianale G et al. | 2008 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1 mT |
| Schmidt-Rohlfing B et al. | 2008 | intact cell/cell culture, chondrocytes (from human articular cartilage of osteoarthritic knee joints) | magnetic field, low frequency, signals/pulses, 50/60 Hz, electrotherapy | 2 mT |
| Girgert R et al. | 2008 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Kanitz MH et al. | 2007 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, 50/60 Hz, electrotherapy, therapeutic/medical device | 1.2 µT |
| Henderson B et al. | 2006 | intact cell/cell culture, human umbilical venous endothelial cells | magnetic field, 50/60 Hz | 10–700 µT |
| Lupke M et al. | 2006 | intact cell/cell culture, human umbilical cord blood-derived monocytes | magnetic field, 50/60 Hz | 1 mT |
| Antonini RA et al. | 2006 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | low frequency, 50/60 Hz, power transmission line, magnetic field | 1–2 mT |
| Reale M et al. | 2006 | intact cell/cell culture, human monocytes | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Savage Jr RE et al. | 2005 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Ventura C et al. | 2005 | intact cell/cell culture, GTR1 cells (derivative of R1 embryonic stem cells) | magnetic field, 50/60 Hz | 0.8 mT |
| Volpe P et al. | 2005 | intact cell/cell culture, FL cells (Friend erythroleukemia cells) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
| Li H et al. | 2005 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz | 0.4 mT |
| Luceri C et al. | 2005 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>/strain DBY747) | magnetic field, low frequency, 50/60 Hz | 0.1–100 µT |
| Bodega G et al. | 2005 | intact cell/cell culture, astroglial cells of P0-P1 Wistar rats | magnetic field, static magnetic field, 50/60 Hz | 1 mT |
| Malagoli D et al. | 2004 | invertebrate, mussel/<i>Mytilus galloprovincialis</i>, whole body | magnetic field, 50/60 Hz | 300–600 µT |
| Somosy Z et al. | 2004 | intact cell/cell culture, Madin-Darby canine kidney (MDCK) cells | magnetic field, 50/60 Hz | 500 µT |
| Olivares-Banuelos T et al. | 2004 | intact cell/cell culture, chromaffin cells (from neonatal Wistar rats) | magnetic field, 50/60 Hz | 700 µT |
| Grassi C et al. | 2004 | intact cell/cell culture, human neuroblastoma cell line (IMR 32) and rat pituitary (GH3) cell line | magnetic field, low frequency, 50/60 Hz, co-exposure | 200–500 µT |
| Czyz J et al. | 2004 | intact cell/cell culture, D3 (murine embryonic stem cell line, p53-deficient and wild type) | magnetic field, 50/60 Hz, power transmission line | 100 µT–2.3 mT |
| Nie K et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line), MCF-7 cells (breast cancer cell line), 3Y1 cells (rat fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
| Shi B et al. | 2003 | intact cell/cell culture, human fibroblasts (derived from neonatal foreskin) | magnetic field, 50/60 Hz | 8.4 mT |
| Nakasono S et al. | 2003 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, 50/60 Hz | 10 mT |
| Santini MT et al. | 2003 | intact cell/cell culture, human osteosarcoma cell lines (MG-63 and Saos-2) | magnetic field, 50/60 Hz | 500 µT |
| Tuncel H et al. | 2002 | animal, rat/Wistar albino, whole body | magnetic field, 50/60 Hz | 5 mT |
| Ding GR et al. | 2002 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Zhou J et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 0.1–0.8 mT |
| Rao RR et al. | 2002 | intact cell/cell culture, IMR 32 (human neuroblastoma cells) | magnetic field, 50/60 Hz | 50–200 µT |
| Richard D et al. | 2002 | intact cell/cell culture, human diploid amniotic fluid cells | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Yomori H et al. | 2002 | intact cell/cell culture, T98G (human glioblastoma) cells | magnetic field, 50/60 Hz | 1–500 µT |
| Still M et al. | 2002 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz, DC, static magnetic field | 10–100 µT |
| Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
